Effect of chronic therapy with proteolytic enzymes on hypertension-induced renal injury in the rat model of Goldblatt hypertension

American Journal of Nephrology

Volumn 18, Issue 6, 1998, Pages 570-576

  Šebeková, Katarina ^a   Dämmrich, Jobst ^b   Fierlbeck, Wolfgang ^c   Krivosiková, Zora ^a   Pa̧czek, Leszek ^d   Heidland, August ^b  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Goldblatt hypertension; Interstitial fibrosis; Malignant nephrosclerosis; Proteases; Proteinuria

Indexed keywords

BROMELAIN; PHLOGENZYM; PLACEBO; PROTEINASE; RUTOSIDE; SODIUM CHLORIDE; TRYPSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; INTERSTITIUM; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY CORTEX; KIDNEY FIBROSIS; KIDNEY INJURY; MALE; MALIGNANT NEOPLASTIC DISEASE; MONONUCLEAR CELL; NEPHROSCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; RENAL ARTERY; RENOVASCULAR HYPERTENSION; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; UREA BLOOD LEVEL;

EID: 0031743336     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013411     Document Type: Article

References (29)

1. Greco BA, Breyer JA: Atherosclerotic ischemic renal disease. Am J Kidney Dis 1997;29:167-187
2. Mailloux LU, Napolitano B, Bellucci AG: Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and out-comes: A 20-year clinical experience. Am J Kidney Dis 1994;24:622-629.
3. Gaciong Z, Paczek L, Bojakowski K, Socha K, Wisniewski M, Heidland A: Beneficial effects of proteases on allograft arteriosclerosis in a rat aortic model. Nephrol Dial Transplant 1996; 11:987-989.
4. Šebeková K, Paczek L, Dämmrich J, Ling H, Spustová V, Gaciong Z, Heidland A: Effects of protease therapy in the remnant kidney model of progressive renal failure. Miner Electrolyte Metab 1997;23:291-295.
5. Lehmann PV: Immunomodulation by proteolytic enzymes Nephrol Dial Transplant 1996, 11:953-955.
6. Hale P, Haynes BF: Bromelain treatment of human T cells removes CD44, CD45RA, E2/ MIC2, CD6, CD7, and Leu8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation. J Immunol 1992;129: 3809-3816.
7. 2M. Ann NY Acad Sci 1994;737:245-262.
8. 2-macroglobulin. Immunol Today 1990;11: 163-166.
9. 2-macroglobulin. J Biol Chem 1989;264:5818-5825.
10. Mai M, Geiger H, Hilgens KF, Veelken R, Mann JFE, Daemmrich J, Luft FC: Early changes in hypertension induced renal injury. Hypertension 1993;22:754-765.
11. Mai M, Hilgers KF, Singer A, Luft FC, Geiger H: Interstitial infiltration of mononuclear cells and adhesion molecule upregulation in hypertensive renal injury. J Am Soc Nephrol 1995;6: 900.
12. Mai M, Fierlbeck W, Geiger H: Differential expression of MCP-1 and RANTES in experimental renovascular hypertension (abstract). J Am Soc Nephrol 1994;5:757.
13. Haller H, Park JK, Dragun D, Lippoldt A, Luft FC: Leukocyte infiltration and ICAM-1 expression in two-kidney one-clip hypertension. Nephrol Dial Transplant 1997;12:899-903.
14. Wilson C, Byrom FB: Renal changes in malignant hypertension. Lancet 1939;i:136-139.
15. Jones DB: Artenal and glomerular lesions associated with severe hypertension. Lab Invest 1974;31:303-313.
16. Paczek L, Teschner M, Schaefer RM, Kovar J, Romen W, Heidland A: Proteinase activity in isolated glomeruli of Goldblatt hypertensive rats. Clin Exp Hypertens [A] 1991;13:339-356.
17. Schaefer RM, Paczek L, Huang S, Teschner M, Schaefer L, Heidland A: Role of glomerular proteinases in the evolution of glomerulosclerosis. Eur J Clin Chem Clin Biochem 1992;30: 641-646.
18. Williams GR, Harrison TR, Grollman A: A simple method for determining the systolic blood pressure in unanesthesized rats. J Clin Invest 1939;18:373-383.
19. Nolan CR, Linas SL: Malignant hypertension and other hypertensive crises; in Schrier R, Gottschalk CW (eds): Diseases of the Kidney, ed 6. Philadelphia, Lippincott, 1996, pp 1475-1554.
20. Morishita R, Gibbons GH, Ellison KE, Lee W, Zhang L, Yu H, Kaneda Y, Ogihara T, Dzau VJ: Evidence for direct local effect of angiotensin in vascular hypertrophy: In vivo gene transfer of angiotensin converting enzyme. J Clin Invest 1994;94:978-984.
21. Morton JJ, Wallace ECH: The importance of renin-angiotensin system in the development and maintenance of hypertension in the two kidney one clip hypertensive rat. Clin Sci 1983; 64:359-370.
22. Orth H, Ritz E: Sodium depletion in accelerated hypertension. N Engl J Med 1975;292: 1133.
23. Eng E, Veniant M, Floege J, Fingerle J, Alpers CE, Menard J, Clozel JP, Johnson RJ: Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension. Am J Hypertens 1994;7:177-185.
24. Šebeková K, Krivosiková Z, Dämmrich J, Paczek L, Heidland A: Sustained systemic oral enzyme treatment ameliorates the progression of nephrosclerosis and tubulo-interstitial fibrosis in the subtotally nephrectomized rats (abstract). Nieren Hochdruckkrh 1997;26:465.
25. 1 in mice. J Clin Invest 1991;87:39-44.
26. Paczek L, Gaciong Z, Bartolomiejczyk I, Gradowska L, Heidland A: Effects of systemic proteases treatment on TGF-β generation in glomeruli from IDDM rats (abstract). Nephrol Dial Transplant 1997;12:A85.
27. Baricos WH, Cortez SL, El-Dahr SS, Schnaper HW: ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/ MMP-2 cascade. Kidney Int 1995;47:1039-1047.
28. Jones CL, Forbes JM, Walker RG, Becker GJ: Activation of renal type IV collagenases (abstract). J Am Soc Nephrol 1996;7:A2549.
29. Wekler BB, Ley CW, Jaffe EH: Stimulation of endothelial cell prostacyclin production by thrombin, trypsin and ionophore. A23187. J Cancer Inst 1978;62:923-930.